LONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Jefferies Innovation in Mental Health Summit at 8:30 am ET on September 22, 2022.
A live audio webcast of the Fireside Chat will be accessible from the “Events” page of the Investors section of the COMPASS website. Each replay of the webcast will be accessible for 30 days after each event. For more information visit go.compasspathways.com
About COMPASS Pathways
COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is to improve the lives of those suffering from mental health problems who are not helped by current treatments. We pioneered the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy Designation by the US Food and Drug Administration (FDA) for treatment-resistant depression (TRD), and we have completed a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites in Europe and North America. . This was the largest randomized, controlled, double-blind clinical trial of psilocybin therapy ever conducted, and our primary data showed a statistically significant (p<0.001) and clinically relevant improvement in severity of depressive symptoms after three weeks for patients who received a single high dose of psilocybin COMP360 with psychological support. We are also conducting phase II clinical trials of COMP360 psilocybin therapy for post-traumatic stress disorder (PTSD) and anorexia nervosa. COMPASS is headquartered in London, UK, with offices in New York and San Francisco in the US Our vision is a world of mental wellness. www.compasspathways.com
Availability of other information about COMPASS Pathways
Investors and others should note that we communicate with our investors and the public through our website (www.compasspathways.com), our investor relations website (ir.compasspathways.com), and on social media. (LinkedIn), including, but not limited to, investor presentations and investor fact sheets, US Securities and Exchange Commission filings, press releases, public conference calls, and webcasts. The information we post on these channels and websites may be considered material information. As a result, we encourage investors, the media and others interested in us to periodically review the information posted on these channels, including the investor relations website. This list of channels may be updated from time to time on our investor relations website and may include additional social media channels. The content of our website or these channels, or any other website that may be accessed from our website or these channels, shall not be deemed incorporated by reference in any file under the Securities Act of 1933.
queries
Media: Amy Lawrence, [email protected]+44 7813 777 919
Investors: Stephen Schultz, [email protected], +1 401 290 7324
.
